Assessing the potential for precision medicine of glucose-lowering drugs in type 2 diabetes mellitus: a meta-regression analysis considering body weight variability from 120 randomized trials

Back

ESC Professional Premium Access

Assessing the potential for precision medicine of glucose-lowering drugs in type 2 diabetes mellitus: a meta-regression analysis considering body weight variability from 120 randomized trials

Session: Partnering with patients through digital health

Topic: Patient Engagement and Personalised Health

Speaker: Doctor K. Vargas (Duesseldorf, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Kris G Vargas

University Hospital Duesseldorf, Duesseldorf (Germany)

0 follower

7 more presentations in this session

Clinician-created video education for patients with atrial fibrillation: a randomised clinical trial

Speaker: Doctor D. McIntyre (Sydney, AU)

Statin non-adherence findings from the My Experience of Taking Statin Medicines Questionnaire (mySTATINmed)

Speaker: Doctor E. Kampouraki (Leeds, GB)

Quality of life after pulmonary veins isolation: outcomes from a digital follow-up program

Speaker: Doctor R. Teixeira (Vila Nova de Gaia, PT)

Conversational artificial intelligence intervention to support patients with atrial fibrillation: process evaluation of a randomised controlled trial

Speaker: Ms R. Trivedi (Sydney, AU)

Knowledge and unmet needs of patients with atrial fibrillation in China: a nationwide cross-sectional survey

Speaker: Professor C. Jiang (Beijing, CN)

Access

Abstract

Slides

Access the full session

Partnering with patients through digital health

Speakers: Doctor K. Vargas, Doctor D. McIntyre, Doctor E. Kampouraki, Doctor R. Teixeira, Ms R. Trivedi...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources